Download Flash Player to view this content.
Health | Jul 5, 2012 | 2:25
Macular degeneration drugs
A new Ontario study has found two drugs, one approved for macular degeneration and other used off-label to treat the disease, don't carry vascular risks, Melanie Nagy reports








